Navigation Links
Drug May Delay Nursing Home Placement for Dementia Patients

Publishing in the September issue of Alzheimer’s Disease and Associated Disorders researchers from the University of South Florida’s Louis de la Parte Florida Mental Health// Institute’s (FMHI) Department of Mental Health, Law and Policy and the School of Aging Studies report finding that treating dementia patients with cholinesterase inhibitors (ChE-Is) may delay placement into nursing homes and provide improved quality of life while helping preserve personal and societal resources.

“Dementia is a very debilitating condition,” said co-author Ross Andel of the USF School of Aging Studies and the Florida Alzheimer’s Disease Research Center. “It affects up to 10 percent of adults over 65 and can account for up to 70 percent of the long-term care, nursing home population. This study provided evidence that treatment with ChE-Is can delay nursing home placement by an average of three and a half months, possibly as a function of temporary stabilization of cognitive and functional abilities.”

According to the Alzheimer’s Association (http://www.alz.org), ChE-Is are designed to increase levels of acetylcholine, a chemical messenger involved in memory and thought processing. The drug, first approved by the FDA in 1993, is known by several trade names, including Aricept, Exelon and Razadyne http://www.alz.org/Resources/
TopicIndex/cholinesteraseinhibitors.asp

To carry out this study, researchers used records from the Florida Medicaid program to follow separate groups of patients over age 60 with dementia who were either taking or not taking ChE-Is and had not been placed in a nursing home.

“The group of patients who were already taking ChE-Is were significantly older and included more women,” said lead author Marion Becker of FMHI. “That those taking ChE-Is were placed in a nursing home more than three months later than those not taking the drug has implications not only for patients and their families, but for controlling the rising costs of Medicaid.”

Cost effectiveness is also a consideration when expensive drugs are used in the Medicaid system.

“The cost of the therapy can be off-set by the financial benefits that come with nursing home placement delay,” Becker added.

Source-Nwswise
SRM
'"/>




Related medicine news :

1. Smoking Delays Pregnancy
2. Delaying Parkinson’s Diseas
3. Lifestyle changes Can Delay the Onset Of Dementia
4. Lifestyle changes Can Delay the Onset Of Dementia
5. Lifestyle changes Can Delay the Onset Of Dementia
6. A Vitamin A Day May Delay The Life span Of HIV Patients
7. Delaying The Progression Of Alzheimer’s Disease
8. The Effects Of Delaying A Delivery Questioned
9. Drug to Delay the Onset of Arthritis
10. Delaying pregnancy may lessen life expectancy of the child
11. In Early Epilepsy Delay in medications Recommended
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital ... area economy by obtaining investment capital for emerging technology companies. SCP has ... have already resulted in more than a million dollars of capital investment for ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, ... stem (iPS) cells and other difficult to transfect cells, announces its launch of ... PluriQ™ G9™ Gene Editing System is a complete system for culturing and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... develops, markets and sells medical devices and wearable sleep ... a strategic cooperation agreement with Hongyuan Supply Chain Management ... on June 20, 2016, to develop Dehaier,s new Internet ... agreement, Dehaier will leverage Hongyuan Supply Chain,s sales platform ...
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology: